Leading product special hormone (paclitaxel injection) is the treatment of ovarian cancer, breast cancer, lung cancer, nasopharyngeal carcinoma and other solid tumors of the first-line drug.

• 主导产品特素(紫杉醇注射液)是治疗卵巢癌、乳腺癌、肺癌、鼻咽癌等实体肿瘤的一线用药。